Covidien has alerted customers for its technetium-99m generators about impending shortages caused by the unexpected shutdown of the Dutch nuclear reactor that serves as its main source of molybdenum-99.
Covidien has alerted customers for its technetium-99m generators about impending shortages caused by the unexpected shutdown of the Dutch nuclear reactor that serves as its main source of molybdenum-99.
General manager Rick Lytle announced the following changes Aug. 27 to the production schedule for its Ultra-Technekow DTE Tc-99m generator:
Covidien depends mainly on the High Flux reactor at Petten in the Netherlands for the production of MO-99 isotope, the precursor isotope to Tc-99m, which is produced as MO-99 decays. The isotope supply chain is susceptible to shortages because of the 66-hour half-life of MO-99.
The Netherlands Energy Research & Consultancy Group announced Aug. 26 that isotope production at the Petten research reactor would cease for at least one month while technicians track down the source of a gas leak between the reactor and the coolant system that was discovered during routine maintenance. Covidien also receives source material from reactors in Europe, Canada, and South Africa. In a written statement, however, the Hazelwood, MO, company said that alternative sources cannot make up for the entire shortfall. The firm is also increasing thallous chloride (TI-201) production as an alternative option for cardiac studies. The company did not disclose how many customers are affected, though they include nuclear medicine facilities in the U.S., Europe, Latin American, Canada, and parts of Asia. For more information from the Diagnostic Imaging archives:
Nuclear medicine braces for effects of Petten reactor shutdown
SNM panel finds no easy path to expand molybdenum-99 supplies
Canadian agency pulls plug on molybdenum reactors
Isotope supply crash drives push for new moly sources
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.